Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias.

Tobias Schupp; Max von Zworowsky; Linda Reiser; Mohammad Abumayyaleh; Kathrin Weidner; Kambis Mashayekhi; Thomas Bertsch; Mohammed L Abba; Ibrahim Akin; Michael Behnes

doi:10.1159/000520310

Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias.

Tobias Schupp, Max von Zworowsky, Linda Reiser, Mohammad Abumayyaleh, Kathrin Weidner, Kambis Mashayekhi, Thomas Bertsch (Co-Autor/-in), Mohammed L Abba, Ibrahim Akin, Michael Behnes

Universitätsinstitut für Klinische Chemie, Laboratoriumsmedizin und Transfusionsmedizin – Zentrallaboratorium

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

3 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	35-45
Fachzeitschrift	PHARMACOLOGY
Jahrgang	107
Ausgabenummer	1-2
DOIs	https://doi.org/10.1159/000520310
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.1159/000520310

Dieses zitieren

Schupp, T., von Zworowsky, M., Reiser, L., Abumayyaleh, M., Weidner, K., Mashayekhi, K., Bertsch, T., Abba, M. L., Akin, I., & Behnes, M. (2022). Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias. PHARMACOLOGY , 107(1-2), 35-45. https://doi.org/10.1159/000520310

Schupp, Tobias ; von Zworowsky, Max ; Reiser, Linda et al. / Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias. in: PHARMACOLOGY 2022 ; Jahrgang 107, Nr. 1-2. S. 35-45.

@article{fff55a3f2a7e4309982dd6a3d571bea3,

title = "Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias.",

keywords = "HEART-FAILURE, EUROPEAN-SOCIETY, ESC GUIDELINES, DYSFUNCTION, TRIAL",

author = "Tobias Schupp and {von Zworowsky}, Max and Linda Reiser and Mohammad Abumayyaleh and Kathrin Weidner and Kambis Mashayekhi and Thomas Bertsch and Abba, {Mohammed L} and Ibrahim Akin and Michael Behnes",

note = "Bertsch: Paracelsus Med Univ, Nuremberg Gen Hosp, Inst Clin Chem Lab Med *** Transfus Med, Nurnberg, Germany;",

year = "2022",

doi = "10.1159/000520310",

language = "English",

volume = "107",

pages = "35--45",

journal = "PHARMACOLOGY ",

issn = "0031-7012",

number = "1-2",

}

Schupp, T, von Zworowsky, M, Reiser, L, Abumayyaleh, M, Weidner, K, Mashayekhi, K, Bertsch, T, Abba, ML, Akin, I & Behnes, M 2022, 'Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias.', PHARMACOLOGY , Jg. 107, Nr. 1-2, S. 35-45. https://doi.org/10.1159/000520310

Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias. / Schupp, Tobias; von Zworowsky, Max; Reiser, Linda et al.
in: PHARMACOLOGY , Jahrgang 107, Nr. 1-2, 2022, S. 35-45.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias.

AU - Schupp, Tobias

AU - von Zworowsky, Max

AU - Reiser, Linda

AU - Abumayyaleh, Mohammad

AU - Weidner, Kathrin

AU - Mashayekhi, Kambis

AU - Bertsch, Thomas

AU - Abba, Mohammed L

AU - Akin, Ibrahim

AU - Behnes, Michael

N1 - Bertsch: Paracelsus Med Univ, Nuremberg Gen Hosp, Inst Clin Chem Lab Med *** Transfus Med, Nurnberg, Germany;

PY - 2022

Y1 - 2022

KW - HEART-FAILURE

KW - EUROPEAN-SOCIETY

KW - ESC GUIDELINES

KW - DYSFUNCTION

KW - TRIAL

U2 - 10.1159/000520310

DO - 10.1159/000520310

M3 - Original Article

C2 - 34879385

SN - 0031-7012

VL - 107

SP - 35

EP - 45

JO - PHARMACOLOGY

JF - PHARMACOLOGY

IS - 1-2

ER -

Schupp T, von Zworowsky M, Reiser L, Abumayyaleh M, Weidner K, Mashayekhi K et al. Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias. PHARMACOLOGY . 2022;107(1-2):35-45. doi: 10.1159/000520310